|
Session 94
Poster Abstracts
Preclinical and Clinical Studies of Topical and Oral PrEP
Wednesday, 1-4 pm
Room: Hall A |
565
 |
Inhibitory Effect of PRO 2000, a Candidate Microbicide, on Dendritic Cell-mediated HIV Transmission
Natalia Teleshova*1, T Chang1, A Profy2, and M Klotman1
1Mt Sinai Sch of Med, New York, NY, US and 2Indevus Pharma Inc, Lexington, MA, US |
| 566 |
Evaluation of the Safety of Carraguard for Vaginal Use by HIV-infected Women: Results from a Phase I, Randomized, Placebo-controlled, 3-Treatment Cross-over Study
Catherine McLean*1, H Jones2, J McNicholl3, J van de Wijgert4, T Medtanavyn5, W Uthaiworavit6, S Whitehead3, J Karon7, P Kilmarx1, and L Markowitz1
1CDC, Atlanta, GA, US; 2Population Council, New York, NY, US; 3Thailand Ministry of Publ Hlth-US CDC Collaboration, Nonthaburi; 4Academic Med Ctr, Univ of Amsterdam, The Netherlands; 5Chiang Rai Provincial Hlth Office, Thailand; 6Chiang Rai Hosp, Thailand; and 7Emergint Corp, Louisville, KY, US |
567
|
HIV Seroconversion Patterns Observed in the Microbicides Development Programme 301 Trial
Ute Jentsch*1, W Stevens1, P Lunga2, S McCormack2, A Nunn2, C Lacey3, and J Weber4
1Univ of the Witwatersrand, Sch of Pathology, Johannesburg, South Africa; 2Med Res Council, London, UK; 3Univ of York, Heslington, UK; and 4Imperial Coll Sch of Med, London, UK |
568
|
Enrollment, Risk Behavior, and Adherence of Injecting Drug Users in an HIV Prevention Trial in Bangkok
K Choopanya1, Michael Martin*2,3, S Vanichseni1, U Sangkum1, R Chuachoowong2, M Leethochawalit4, S Chiamwongpaet4, S Kittimunkong5, J McNicholl2,3, P Suntharasamai1, and The Bangkok Tenofovir Study Group
1Bangkok Tenofovir Study Group, Thailand; 2Thailand Ministry of Publ Hlth-US CDC Collaboration, Nonthaburi; 3CDC, Atlanta, GA, US; 4Bangkok Metropolitan Admin, Thailand; and 5Thailand Ministry of Publ Hlth |
569
|
iPrEx: A Timely Intervention Unfolds in a Population of Eminent Risk of HIV infection
Jeff McConnell*1, R Grant1,2, P Goicochea3, J Guanira4, M Casapia5, O Guerra4, L Vargas3, V McMahan1, and J Lama3,4
1Gladstone Inst of Virology and Immunology, San Francisco, CA, US; 2Univ of California, San Francisco, US; 3Investigaciones Medicas en Salud, Lima, Peru; 4Civil Impacta Salud y Educacion, Lima, Peru; and 5Assn Civil Selva Amazonica, Iquitos, Peru |
570
|
No Evidence of Drug-resistance Mutations in a Seroconverter Exposed to Tenofovir Disoproxil Fumarate Chemoprophylaxis in Africa
R Atchison1, L Peterson2, T Leigler3, W Cates2, and Rm Grant*1,3
1Gladstone Inst of Virology and Immunology, San Francisco, CA, US; 2Family Hlth Intl, Durham, NC, US; and 3Univ of California, San Francisco, US |
|
